Tsumura & Co banner

Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 3 930 JPY -0.15%
Market Cap: ¥301.7B

Tsumura & Co
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tsumura & Co
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Tsumura & Co
TSE:4540
EPS (Diluted)
¥389
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
EPS (Diluted)
¥71
CAGR 3-Years
-26%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
EPS (Diluted)
¥164
CAGR 3-Years
75%
CAGR 5-Years
35%
CAGR 10-Years
-10%
Otsuka Holdings Co Ltd
TSE:4578
EPS (Diluted)
¥687
CAGR 3-Years
41%
CAGR 5-Years
20%
CAGR 10-Years
14%
Chugai Pharmaceutical Co Ltd
TSE:4519
EPS (Diluted)
¥263
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
22%
Astellas Pharma Inc
TSE:4503
EPS (Diluted)
¥180
CAGR 3-Years
34%
CAGR 5-Years
19%
CAGR 10-Years
8%
No Stocks Found

Tsumura & Co
Glance View

Market Cap
301.7B JPY
Industry
Pharmaceuticals

Tsumura & Co., a venerable name in the herbal medicine industry, traces its roots back to 1893. Emerging from Japan's rich pharmacopeia tradition, the company has carved a niche by blending age-old herbal knowledge with contemporary research and quality control. This synergy allows Tsumura to thrive in the modern marketplace, offering Kampo—a traditional Japanese herbal medicine—as their primary product line. Tsumura stands out in its meticulous approach to sourcing high-quality raw materials, employing state-of-the-art technology to ensure efficacy and safety. This rigorous quality assurance not only honors the integrity of traditional formulas but also aligns with the stringent standards of modern healthcare. In its pursuit of growth, Tsumura expertly navigates the delicate balance between tradition and innovation. The company generates revenue through the sale of its Kampo products, which are widely used in clinics and hospitals across Japan, reflecting a significant integration into the mainstream healthcare system. Additionally, Tsumura's strategic collaborations with pharmaceutical companies expand its reach into international markets. Through educational initiatives, they further advocate for the understanding and acceptance of herbal medicine globally. By continually investing in research and development, Tsumura aims to bolster their product offerings, ensuring that the ancient wisdom of Kampo remains relevant in today's fast-paced, health-conscious world.

Intrinsic Value
3 472.39 JPY
Overvaluation 12%
Intrinsic Value
Price

See Also

What is Tsumura & Co's EPS (Diluted)?
EPS (Diluted)
389 JPY

Based on the financial report for Dec 31, 2025, Tsumura & Co's EPS (Diluted) amounts to 389 JPY.

What is Tsumura & Co's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
8%

Over the last year, the EPS (Diluted) growth was 9%. The average annual EPS (Diluted) growth rates for Tsumura & Co have been 15% over the past three years , 14% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett